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TO THE EDITOR
A 17-year-old girl presented with a 3-day history of epistaxis, vaginal bleeding and petechiae over the lower extremities. The patient had been feeling unwell with productive cough but no hemoptysis, fever, chills, poor appetite and weight loss for 2 months. She had no known blood disorder. All vital signs were normal apart from hypotension (105/65 mmHg). The patient had a pale appearance with multiple petechiae over the lower extremities. There were diminished breath sounds with scattered crackles over the right lower chest. Her physical examina- tion was otherwise unremarkable. Laboratory findings revealed low hemoglobin (Hb) of 7.8 g/dL, low platelet count of 36 ×10 3 /µL and high ESR of 115 mm/hr. A bone marrow examination was unremarkable. The sputum was positive for AFB on three consecutive smear examinations. A PCR analysis for Mycobacterium tuberculosis (MTb) turned out positive. The isolated MTb was susceptible to both isoniazid and rifampicin. The rest of her laboratory tests were normal. A chest X-ray (CXR) and a computed tomography (CT) revealed mediastinal and right hilar lymphadenopathy with consolidation of the right middle and lower lobes (Figures 1  and 2 ). CT also showed tree-in-bud pattern of the right upper lobe. Based on the clinical, laboratory and radiological findings, she was diagnosed as having idiopathic thrombocytopenic purpura (ITP) in association with active tuberculosis (TB). Based on the American Society of Hematology, ITP is a diagnosis of exclusion, which is made by confirming the presence of isolated thrombocytopenia and by excluding concurrent causes of thrombocytopenia. 1 The association between TB and ITP is exceedingly uncommon. [2] [3] [4] Although the mechanism of this phenomenon is unclear, MTb could nonspecifically activate a clone of B lymphocytes, which might produce anti-platelet autoantibodies. 3 The patient was treated with high-dose intravenous immunoglobulin (IVIg) (20 g/day, 5 days) and corticosteroid along with anti-TB drugs. Despite discontinuing IVIg and corticosteroid during the treatment, platelet count remained normal; this strongly suggests the causative role of MTb in inducing ITP. Follow-up period showed recurrence of neither thrombocytopenia nor TB. In conclusion, it is important to consider TB in the differential diagnosis of ITP, particularly in high TB-burden areas.
